The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.
River Terrace 2
B1: Laboratory Diagnosis of Rectal Chlamydia trachomatis Lymphogranuloma Venereum Infection
|Learning Objectives: By the end of the session, participants should be able to:
1. Describe varied approaches to the laboratory diagnosis of rectal LGV infections.
2. Outline the complexities for reporting laboratory results for patient management.
|3:00 PM||Overview -- John Papp, PhD|
|3:20 PM||51||Nucleic acid amplification tests for the diagnosis Chlamydia trachomatis rectal infections|
Laura Hinkle Bachmann, Robert Johnson, Hong Cheng, Lauri Markowitz, John Papp, Tracy Burkett, Edward Hook III
|3:40 PM||52||Regulatory issues for using tests that are not FDA cleared|
John R Papp
|4:00 PM||53||Detection of LGV in New York City|
Julia A. Schillinger, Ronald Limberger
|4:20 PM||54||Detection of LGV in San Francisco|
Charlotte K. Kent, Mark Pandori
|4:40 PM||55||Development of a real time nucleic acid amplification assay for LGV|
|5:00 PM||Summary -- John Papp, PhD|